These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23875476)

  • 21. Basic cancer research is essential for the success of personalised medicine.
    Yarden Y; Caldas C;
    Eur J Cancer; 2013 Aug; 49(12):2619-20. PubMed ID: 23726268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox-inactive analogue of tocotrienol as a potential anti-cancer agent.
    Yano T; Sato A; Sekine M; Virgona N; Ota M
    Anticancer Agents Med Chem; 2013 Mar; 13(3):496-501. PubMed ID: 22721395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calculated resistance in cancer.
    Sawyers CL
    Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
    [No Abstract]   [Full Text] [Related]  

  • 24. [The importance of a SNiP of the MDM2 gene to modulate the p53 pathway and the predisposition to cancer].
    Larsen CJ
    Bull Cancer; 2011 Jan; 98(1):10. PubMed ID: 21591298
    [No Abstract]   [Full Text] [Related]  

  • 25. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
    Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
    Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance].
    Rybalkina EIu; Stromskaia TP; Ovchinnikov LP; Stavrovskaia AA
    Vopr Onkol; 2013; 59(5):623-8. PubMed ID: 24260892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs.
    Patanè S
    Int J Cardiol; 2014 Oct; 176(3):1306-8. PubMed ID: 25131921
    [No Abstract]   [Full Text] [Related]  

  • 28. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
    Gillet JP; Gottesman MM
    Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors.
    Mancini M; Yarden Y
    Semin Cell Dev Biol; 2016 Feb; 50():164-76. PubMed ID: 26428295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emergence of resistance to targeted cancer therapeutics.
    Mellinghoff IK; Sawyers CL
    Pharmacogenomics; 2002 Sep; 3(5):603-23. PubMed ID: 12223047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics for identifying mechanisms and biomarkers of drug resistance in cancer.
    Li XH; Li C; Xiao ZQ
    J Proteomics; 2011 Nov; 74(12):2642-9. PubMed ID: 21964283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer genetics.
    Ponder BA
    Nature; 2001 May; 411(6835):336-41. PubMed ID: 11357140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
    Merlio JP
    Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
    [No Abstract]   [Full Text] [Related]  

  • 35. New insights into oncogene addiction found.
    Garber K
    J Natl Cancer Inst; 2007 Feb; 99(4):264-5, 269. PubMed ID: 17312299
    [No Abstract]   [Full Text] [Related]  

  • 36. Signaling by exosomal microRNAs in cancer.
    Falcone G; Felsani A; D'Agnano I
    J Exp Clin Cancer Res; 2015 Apr; 34(1):32. PubMed ID: 25886763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focus issue: Rendering resistance futile.
    Adler EM; Gough NR
    Sci Signal; 2011 Mar; 4(166):eg3. PubMed ID: 21447795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAMA Oncology Patient Page. The Evolution of a Cancer.
    West HJ; Jin JO
    JAMA Oncol; 2015 Sep; 1(6):850. PubMed ID: 26247697
    [No Abstract]   [Full Text] [Related]  

  • 39. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
    Horlings HM; Shah SP; Huntsman DG
    JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
    [No Abstract]   [Full Text] [Related]  

  • 40. Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis.
    McCubrey JA; Abrams SL; Fitzgerald TL; Cocco L; Martelli AM; Montalto G; Cervello M; Scalisi A; Candido S; Libra M; Steelman LS
    Adv Biol Regul; 2015 Jan; 57():75-101. PubMed ID: 25453219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.